Toyosi Onwuemene/LinkedIn
Jun 11, 2026, 16:25
Toyosi Onwuemene: What Clinicians Reveal About Bleeding and Clotting Care
Toyosi Onwuemene, Associate Professor with tenure Duke University School of Medicine, shared a post on LinkedIn:
”A patient developed a pulmonary embolism.
He was started on anticoagulation.
Two days later, he developed gastrointestinal bleeding.
Anticoagulation was stopped.
Multiple specialists became involved.
One question remained:
When should anticoagulation be restarted?
It seemed like a straightforward question.
Yet, no one owned the decision.
In the latest edition of Hematology Access Insights, I explore what clinician interviews revealed about expertise, access, and decision-making in bleeding and clotting care.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 04:43Tom Tang: Preventing Post Thrombotic Syndrome Starts With Early DVT Prevention
-
Sep 17, 2026, 04:35Veronica Sanchez: Menopause as a Risk for Heart Disaese
-
Sep 17, 2026, 03:20Jessica Frye: Understanding VTE in Pregnancy and the Postpartum Period
-
Sep 17, 2026, 03:04Leonardo Roever: Exploring the Role of Glutamine Metabolism in Atherosclerosis
-
Sep 17, 2026, 02:36Wolfgang Miesbach: Effectiveness of Avatrombopag in ITP Treatment
-
Sep 17, 2026, 02:34Aleksandar Sič: The Endothelium and Cardiovascular Toxicity in Blood Cancers
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?